| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/02/2008 | CA2267671C Method for manufacturing expanded hematopoietic cells with stem cell factor polypeptide |
| 12/02/2008 | CA2265484C Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 12/02/2008 | CA2263439C Improved western blot test for the identification of antibodies specific against the hcmv virus |
| 12/02/2008 | CA2241918C Peanut allergens and methods |
| 12/02/2008 | CA2215397C Inhibition of tau-tau-association |
| 12/02/2008 | CA2140538C Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells |
| 12/02/2008 | CA2120527C Helicobacter pylori genes necessary for the regulation and the maturation of urease and their use |
| 12/02/2008 | CA2100268C Method for culturing and transforming human stem cell-containing compositions |
| 12/01/2008 | CA2590593A1 Mutated hoxb4 proteins with improved stability, and methods of use thereof |
| 12/01/2008 | CA2589155A1 An attenuated strain of leptospira not expressing the loa22 protein and its use thereof against a leptospiral disease |
| 11/27/2008 | WO2008144736A1 Parkin substrate and assay |
| 11/27/2008 | WO2008144700A2 Simian t-cell lymphotropic virus type 3 west african subtype d |
| 11/27/2008 | WO2008144590A2 Long lasting modified antifusogenic peptide for preventing hiv infection |
| 11/27/2008 | WO2008144142A1 Memory and learning impairments associated with disruption of ephrin receptor a6 (epha6) gene |
| 11/27/2008 | WO2008143977A1 Method for producing mature vwf from vwf pro-peptide |
| 11/27/2008 | WO2008143954A2 Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto |
| 11/27/2008 | WO2008143936A1 Methods of enhancing adenoviral delivery |
| 11/27/2008 | WO2008143914A1 Novel methods for recovery of leaf proteins |
| 11/27/2008 | WO2008143910A2 A strategy for cloning and expressing the extracellular domains of receptors as soluble proteins |
| 11/27/2008 | WO2008143797A1 Methods of producing a secreted protein |
| 11/27/2008 | WO2008143794A1 Fusion molecules and il-15 variants |
| 11/27/2008 | WO2008143717A2 Methods of determining lethality of pathogens and malignancies involving replikin peak genes |
| 11/27/2008 | WO2008143705A2 Methods and compositions for rapid inactivation of proteins |
| 11/27/2008 | WO2008143666A2 Crystal structures of neuropilin fragments and neuropilin-antibody complexes |
| 11/27/2008 | WO2008143594A1 Hypoallergenic polypeptides |
| 11/27/2008 | WO2008143494A1 Assay for detection of prostate cancer by means of proteolytic hsa markers |
| 11/27/2008 | WO2008143199A1 Novel polypeptide, material for affinity chromatography, and method for separation and/or purification of immunoglobulin |
| 11/27/2008 | WO2008143151A1 Therapeutic agent and detection reagent for arteriosclerotic disease which targets for thallusin |
| 11/27/2008 | WO2008142693A2 Regulation of myelination by nectin-like (necl) molecules |
| 11/27/2008 | WO2008142664A2 Exposed thymidine kinase 1 peptides, ligands and methods employing the same |
| 11/27/2008 | WO2008142517A2 Synthetic peptide having anti-inflammatory and anti-microbic properties |
| 11/27/2008 | WO2008142442A1 Sox9 as a target for fibrosis therapy |
| 11/27/2008 | WO2008142364A2 Rhd6 and its use in modulating plant root hair development |
| 11/27/2008 | WO2008142194A1 Method for the in vitro diagnosis/prognosis of huntington's chorea |
| 11/27/2008 | WO2008142163A2 Plants having enhanced yield-related traits and a method for making the same |
| 11/27/2008 | WO2008142146A1 Yield enhancement in plants by modulation of zmphdf |
| 11/27/2008 | WO2008142133A1 Lyophilised antigen composition |
| 11/27/2008 | WO2008142034A2 Plants with increased tolerance and/or resistance to environmental stress and increased biomass production |
| 11/27/2008 | WO2008141806A1 Methods and means for producing glycoproteins with altered glycosylation pattern in higher plants |
| 11/27/2008 | WO2008141786A2 Peptides having the biological activity of vasoactive intestinal peptide (vip) and their use for the treatment of lung diseases |
| 11/27/2008 | WO2008141651A1 Efficient cell culture system for hepatitis c virus genotype 5a |
| 11/27/2008 | WO2008141480A1 Human angiostatin interacting and tumor metastasis involving protein variants and uses thereof |
| 11/27/2008 | WO2008141448A1 Mutant reoviruses and methods of making and using |
| 11/27/2008 | WO2008141400A1 A novel aetiologic agent of acute gastroenteritis (age), diagnostic methods and therapeutic treatment thereof |
| 11/27/2008 | WO2008124358A3 Detection of anaplasma platys |
| 11/27/2008 | WO2008115525A8 Metal-binding therapeutic peptides |
| 11/27/2008 | WO2008114577A3 Antibacterial peptide |
| 11/27/2008 | WO2008103966A3 Compositions and methods using toll-like receptors and unc93b |
| 11/27/2008 | WO2008098749A3 Peptides derived from the major allergen of ragweed (ambrosia artemisiifolia) and uses thereof |
| 11/27/2008 | WO2008097606A3 Compositions and methods for drought tolerance |
| 11/27/2008 | WO2008089491A3 Modifications of peptide compositions to increase stability and delivery efficiency |
| 11/27/2008 | WO2008088582A3 Methods and materials related to trail isoforms |
| 11/27/2008 | WO2008079566A3 Compositions and methods of modulating cell growth and motility |
| 11/27/2008 | WO2008073351A3 Uses of cerberus, coco and derivatives thereof |
| 11/27/2008 | WO2008073184A3 Genetic incorporation of unnatural amino acids into proteins in mammalian cells |
| 11/27/2008 | WO2008063321A3 Gpr81-ligand complexes and their preparation and use |
| 11/27/2008 | WO2008059996A3 Agent that modulates physiological condition of pests, involved in insect vesicle-fusing atpase activity |
| 11/27/2008 | WO2008057313A3 Methods of using e2f2 for the treatment of hypertension |
| 11/27/2008 | WO2008039483A3 Modified self-assembling peptides |
| 11/27/2008 | WO2008032219A3 Making influenza virus vaccines without using eggs |
| 11/27/2008 | WO2008030988A3 Selectively targeted antimicrobial peptides and the use thereof |
| 11/27/2008 | WO2008021367A3 Moenomycin biosynthesis-related compositions and methods of use thereof |
| 11/27/2008 | WO2008011379A3 Oxidized apoa1 determination by mass spectrometry |
| 11/27/2008 | WO2008011193A3 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders |
| 11/27/2008 | WO2008006087A3 Antibodies to conformationally trapped proteins |
| 11/27/2008 | WO2007126847A3 Coadministration of alpha-fetoprotein and a disease modifying anti-rheumatic drug for treating inflammatory arthritic disease |
| 11/27/2008 | WO2007101002A3 A novel non-selective cation channel in neuronal cells and methods for treating brain swelling |
| 11/27/2008 | WO2007084743A3 Intraventricular protein delivery for amyotrophic lateral sclerosis |
| 11/27/2008 | WO2005116235A8 Endothelial cell apoptosis induced by fibrinogen gamma chain c-terminal fragment |
| 11/27/2008 | WO2004092209A9 S. pneumoniae antigens |
| 11/27/2008 | US20080295202 Soybean promoters SC194 and flower-preferred expression thereof in transgenic plants |
| 11/27/2008 | US20080295201 Soybean promoters LTP2 and flower-preferred expression thereof in transgenic plants |
| 11/27/2008 | US20080295190 comprising a Cricetulus griseus ( FAIM, FADD, PDCD6 and Requiem) sequence capable of mediating apoptosis of cells |
| 11/27/2008 | US20080293924 Process For the Isolation and/or Purification of Proteins |
| 11/27/2008 | US20080293923 Crystal structure of the complex of hepatocyte growth factor beta chain with met receptor and methods of use |
| 11/27/2008 | US20080293922 Beta-amyloid binding factors and inhibitors thereof |
| 11/27/2008 | US20080293920 Arginine Analogs, and Methods for Their Synthesis and Use |
| 11/27/2008 | US20080293919 Fibrous Protein Fusions and Use Thereof in the Formation of Advanced Organic/Inorganic Composite Materials |
| 11/27/2008 | US20080293918 Method and apparatus for extraction of protein material from arthropod glands and a membrane formed therefrom |
| 11/27/2008 | US20080293917 Peptide Purification By Means Of Metal Ion Affinity Chromatography |
| 11/27/2008 | US20080293813 Compositions and Methods |
| 11/27/2008 | US20080293771 Azacyclylbenzamide derivatives as histamine-3 antagonists |
| 11/27/2008 | US20080293663 Cellular genes regulated by hiv-1 infection and methods of use thereof |
| 11/27/2008 | US20080293660 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 11/27/2008 | US20080293638 Albumin-fused ciliary neurotrophic factor |
| 11/27/2008 | US20080293637 Cross-linked collagen and uses thereof |
| 11/27/2008 | US20080293636 Protein Constructs Designed for Targeting and Lysis of Cells |
| 11/27/2008 | US20080293629 Albumin Fusion Proteins |
| 11/27/2008 | US20080293627 Thyrotropin Receptor Preparations, Binding Regions Thereof, Antibody and Hormone Interactions Therewith, and Uses Thereof |
| 11/27/2008 | US20080293625 Diagnosis of Inflammatory Bowel Diseases, More Particularly Ulcerative Colitis |
| 11/27/2008 | US20080293623 Enriched haptoglobin polymers for the treatment of disease |
| 11/27/2008 | US20080293610 Use and production of storage-stable neutral metalloprotease |
| 11/27/2008 | US20080293583 Methods for diagnosing mood disorders |
| 11/27/2008 | US20080293149 very early marker of fertilization and embryo viability; binds to anti-CD2 antibody; Infertility |
| 11/27/2008 | US20080293134 Human Cancer Suppressor Gene, Protein Encoded Therein, Expression Vector Containing Same |
| 11/27/2008 | US20080293116 Ovary-specific genes and proteins |
| 11/27/2008 | US20080293103 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 11/27/2008 | US20080293087 Sulfonylurea receptor short forms from mitochondria and uses thereof |
| 11/27/2008 | US20080293077 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses |
| 11/27/2008 | US20080293046 RNA detection assays |